You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
|
|---|---|
| Published in |
Current Neuropharmacology, September 2014
|
| DOI | 10.2174/1570159x12666140619204251 |
| Pubmed ID | |
| Authors |
Gianluca Serafini, Robert H Howland, Fabiana Rovedi, Paolo Girardi, Mario Amore |
| Abstract |
At least 10-20% of the patients suffering from depression meet criteria for treatment-resistant depression (TRD). In the last decades, an important role of glutamate in mood modulation has been hypothesized and ketamine, a non noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptors, has been demonstrated to be effective in both MDD and TRD. However, concerns emerged about the optimal dosage, and frequency of administration of this treatment. |
X Demographics
The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 38% |
| Canada | 1 | 3% |
| India | 1 | 3% |
| Germany | 1 | 3% |
| Australia | 1 | 3% |
| Iceland | 1 | 3% |
| Unknown | 13 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 93% |
| Scientists | 1 | 3% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 278 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Mexico | 1 | <1% |
| New Zealand | 1 | <1% |
| Poland | 1 | <1% |
| Unknown | 273 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 59 | 21% |
| Researcher | 36 | 13% |
| Student > Master | 35 | 13% |
| Student > Ph. D. Student | 25 | 9% |
| Other | 18 | 6% |
| Other | 46 | 17% |
| Unknown | 59 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 22% |
| Neuroscience | 33 | 12% |
| Psychology | 30 | 11% |
| Agricultural and Biological Sciences | 16 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 6% |
| Other | 41 | 15% |
| Unknown | 80 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 150. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2023.
All research outputs
#279,447
of 25,791,495 outputs
Outputs from Current Neuropharmacology
#21
of 945 outputs
Outputs of similar age
#2,380
of 249,584 outputs
Outputs of similar age from Current Neuropharmacology
#1
of 4 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 945 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,584 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them